"The health insurance system is so complex that it is hard to parse the blame for this injustice. The drug companies, especially the biotechnology companies, are at the root of the problem; they often charge exorbitant prices for monopoly drugs that were developed with heavy government assistance. Washington needs to rein them in by encouraging generic competition for biological drugs and allowing government programs to negotiate lower prices."

I AGREE with that statement too!! It's not like they drop down the price once they pay off R&D and have a big enough market to make huge profits . . . they just keep upping the price higher. These drugs are a cash-cow for them.

Cherie